Varma Mutual Pension Insurance Co Has $10.41 Million Position in Axon Enterprise, Inc $AXON

Varma Mutual Pension Insurance Co grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 9.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,500 shares of the biotechnology company’s stock after purchasing an additional 1,200 shares during the quarter. Varma Mutual Pension Insurance Co’s holdings in Axon Enterprise were worth $10,406,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Willis Johnson & Associates Inc. increased its holdings in Axon Enterprise by 11.0% in the third quarter. Willis Johnson & Associates Inc. now owns 425 shares of the biotechnology company’s stock worth $305,000 after purchasing an additional 42 shares in the last quarter. Caprock Group LLC bought a new position in shares of Axon Enterprise during the 3rd quarter worth approximately $666,000. Rhumbline Advisers grew its position in shares of Axon Enterprise by 1.8% during the 3rd quarter. Rhumbline Advisers now owns 155,186 shares of the biotechnology company’s stock worth $111,368,000 after buying an additional 2,701 shares during the period. Stratos Wealth Partners LTD. increased its stake in shares of Axon Enterprise by 8.3% in the 3rd quarter. Stratos Wealth Partners LTD. now owns 7,361 shares of the biotechnology company’s stock valued at $5,283,000 after acquiring an additional 563 shares in the last quarter. Finally, Stratos Wealth Advisors LLC increased its stake in shares of Axon Enterprise by 17.3% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 828 shares of the biotechnology company’s stock valued at $594,000 after acquiring an additional 122 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. Barclays cut their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a research report on Thursday, November 6th. Royal Bank Of Canada started coverage on Axon Enterprise in a report on Monday, November 17th. They issued an “outperform” rating and a $860.00 price target on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday, December 29th. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, November 5th. Finally, Morgan Stanley reduced their price target on shares of Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating for the company in a research report on Wednesday, December 17th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $805.71.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $619.01, for a total value of $6,190,100.00. Following the completion of the sale, the chief executive officer owned 3,100,997 shares in the company, valued at approximately $1,919,548,152.97. This trade represents a 0.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the transaction, the president directly owned 249,502 shares in the company, valued at approximately $137,874,805.20. This represents a 7.42% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 48,040 shares of company stock worth $27,249,338. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $429.67 on Friday. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. The business has a 50 day moving average price of $557.56 and a 200-day moving average price of $648.72. The company has a market cap of $33.91 billion, a PE ratio of 135.97, a price-to-earnings-growth ratio of 13.13 and a beta of 1.48.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.